T

TCG X

8 employees

TCG Crossover is a healthcare investment firm dedicated to advancing disruptive medicines and supporting companies.

Investor insights

Sectors invested in

Biotechnology20
Health Care15
Medical7
Life Science6
Pharmaceutical6
Therapeutics5
Health Diagnostics2
Immuno-Oncology2
Genetics2
Biopharma2
Molecular Biology2
Emergency Medicine1
infectious disease1
Wellness1
Personal Health1
Respiratory syncytial virus1
Vaccines1
Vaccine Development1
VLPs1
Infectious Disease1

Funding rounds participated in

$106M sweet spot round size

Most of their 22 investments are in rounds between $86M and $150M

Investor type

Hedge Fund
Venture Capital

Basic info

Industry

biotechnology research

Sectors

Financial Services
Health Care
Alternative Medicine
Venture Capital
Life Science

Date founded

2020

Investments made

C

COMPASS Pathways raised $125M on August 16, 2023

Investors: Vivo Capital, Soleus Capital Management, L.P., Laurion Capital Management LP, Partner Fund Management, RA Capital Management, L.P., Surveyor Capital, Logos Global Management, LP, Armistice Capital LLC and TCG X

A

AN2 Therapeutics raised $70M on August 15, 2023

Investors: Avidity Partners, Adage Capital Management, RA Capital Management, L.P., Surveyor Capital, Marshall Wace and TCG X

T

Taysha Gene Therapies raised $150M on August 14, 2023

Investors: RTW Investments, LP, Octagon Capital Advisors, GordonMD Global Investments LP, PBM Capital Group, RA Capital Management, L.P., The Invus Group, B Capital Group and TCG X

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Avidity Partners, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc, Longitude Capital and TCG X

C

CG Oncology raised $105M on August 2, 2023

Investors: Decheng Capital, Foresite Capital, Malin Corporation plc, Longitude Capital, Avidity Partners, RA Capital Management, L.P. and TCG X

U

Undisclosed raised $200M on June 8, 2023

Investors: Omega Funds, Samsara BioCapital, OrbiMed Advisors, Enavate Sciences, Decheng Capital, Wellington Management and TCG X

U

Undisclosed raised $150M on June 5, 2023

Investors: Sofinnova Ventures, Russia technology fund, Wellington Management and TCG X

C

Carmot Therapeutics, Inc. raised $150M on May 25, 2023

Investors: Willett Advisors LLC, The Column Group, Millennium Partners, RA Capital Management, L.P. and TCG X

I

Icosavax, Inc. raised $68M on May 22, 2023

Investors: Logos Global Management, LP, Vivo Capital and TCG X

V

VectivBio AG raised $125M on October 13, 2022

Investors: Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Marshall Wace, Vivo Capital, Driehaus Capital Management LLC, Forbion and TCG X

FAQ